The Popular Story
  • About Us
  • Articles
  • Success Stories
  • Contact Us
  • About UsArticlesSuccess StoriesContact Us
HomeTop NewsEntertainmentSportsLifestyleAstrologyWorld
Magazine
All IssuesIconic Personalities of the Year 2026July 2026 | The Business Visionaries EditionThe Popular Story 40 Under 40Top 50 Iconic Personalities of 2026
Lists
40 Under 40Top 50 Iconic PersonalitiesIconic Personalities of the Year
Connect+
InstagramFacebookXYouTubeLinkedIn
All Categories
HomeTop NewsEntertainmentSportsLifestyleAstrologyWorldMagazine40 Under 40Top 50 Iconic PersonalitiesIconic Personalities of the YearAbout Us
Font ResizerAa
The Popular StoryThe Popular Story
Search
Follow US
Copyright © 2025-2026 MP Media. All rights reserved.
The Popular Story > Top News > Cancer Drug Prices Fall Sharply as 30% Margin Cap on 137 Medicines Takes Effect
Top News

Cancer Drug Prices Fall Sharply as 30% Margin Cap on 137 Medicines Takes Effect

By Vinaykant Patel Last updated: November 11, 2026 6 Min Read
Share
Assorted medicine tablets and capsules on a plate
Featured image: epSos.de, via Wikimedia Commons (CC BY 2.0)

Cancer patients across India should now be paying much less for many of their medicines. From 9 November 2026, a cap on trade margins covering 137 anti-cancer drugs is in force, and companies have already cut the printed prices of more than a thousand formulations. Some medicines now cost a small fraction of what they did last month.

Contents
What the government has changedHow big are the price cuts?Why the government used special powersRules for companies, chemists and hospitalsHow patients can check prices

The order comes from the National Pharmaceutical Pricing Authority (NPPA), which works under the Department of Pharmaceuticals. It was notified on 17 October and gave companies time to revise their maximum retail prices (MRPs) before the deadline.

What the government has changed

The NPPA has capped the trade margin on 137 non-scheduled anti-cancer medicines at 30 per cent. Trade margin is the gap between the price a company charges its stockist or distributor and the MRP the patient pays, not counting GST. Under the new rule, a drug sold to a distributor at Rs 70 cannot carry a pre-tax MRP above Rs 100.

The cap covers all strengths and dosage forms, single drugs as well as combinations. Patented medicines are included. Among the drugs named in reports are pembrolizumab, nivolumab, durvalumab, osimertinib, olaparib, ibrutinib, pegfilgrastim and denosumab, several of which are used in immunotherapy and targeted therapy.

How big are the price cuts?

According to data released on 10 November and reported by ETV Bharat, 85 companies had reported revised MRPs for 1,366 product lines of 121 drugs by 9 November. Earlier government figures showed price cuts on 1,031 formulations, with 600 brands cutting prices by more than half. The steepest cut so far is 96.45 per cent.

A few examples from the revised lists:

  • Bevacizumab 100 mg (Bryxta, Zydus): down from Rs 25,995 to Rs 3,318
  • Abiraterone 250 mg (Abirone): down from Rs 41,250 to Rs 3,218.23
  • Palbociclib 125 mg (Palbopro): down from Rs 40,421.33 to Rs 2,720
  • Pertuzumab 420 mg (Lupiher 2, Lupin): down from Rs 83,520 to Rs 37,358.35

The government estimates that consumers will save about Rs 3,502 crore a year. This is an official estimate, and the real figure will depend on how many patients buy these brands and whether pharmacies and hospitals actually charge the new prices.

Of the 137 drugs on the list, 10 to 15 are not yet sold in India. The margin cap will apply to them as soon as they are launched.

Why the government used special powers

Most of these medicines are not on the National List of Essential Medicines, so their prices were not directly controlled. Under the Drugs (Prices Control) Order, 2013, companies can raise the MRP of such drugs by up to 10 per cent a year. That rule limits increases but does nothing about prices that are already high.

So the government used Paragraph 19 of the order, which allows it to fix or revise prices in extraordinary circumstances and in the public interest. The list was drawn up on the advice of an expert committee set up by the Directorate General of Health Services.

India has tried this before. In 2019, a pilot capped margins at 30 per cent on 42 anti-cancer drugs, and MRPs of 526 brands fell by up to 90 per cent. The new order is far wider.

The need is growing. Health Ministry figures shared with Parliament put estimated cancer cases at nearly 15.7 lakh in 2025, up from about 14.26 lakh in 2021. For many families, treatment costs run into lakhs of rupees, and medicines make up a large share of the bill.

Rules for companies, chemists and hospitals

Companies must report revised prices to the NPPA, publish them on their websites and inform retailers and hospitals. Drugs that were already priced below the new ceiling cannot be made costlier. Firms that fail to cut prices must deposit the overcharged amount with interest.

Retailers, dealers, hospitals and medical institutions must display the revised price lists prominently, both on their premises and on their websites. State Drug Controllers will monitor compliance, and the government has warned of strict action against chemists and hospital pharmacies that overcharge.

How patients can check prices

If you or a family member is on cancer treatment, a few simple checks can help:

  • Compare the price on the pack with the revised list on the NPPA website or the Pharma Sahi Daam mobile app.
  • Ask the hospital pharmacy for its displayed price list.
  • Keep your prescription and purchase bill. You will need them if you file a complaint.
  • Report overcharging through the Pharma Sahi Daam app, the NPPA helpline (1800-11-1255) or the NPPA monitoring email.

Do not change or stop any treatment because of a price difference; talk to your oncologist first.

Reporting based on ETV Bharat, Greater Kashmir, The Public World, Organiser, VOH Network

Featured image: epSos.de, via Wikimedia Commons (CC BY 2.0)

Subscribe to Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

[mc4wp_form]

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[mc4wp_form]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Email Copy Link Print
By Vinaykant Patel
Vinaykant Patel is an engineer by profession who has developed a strong association with journalism over the past five years. Combining his technical background with an interest in news and public affairs, he brings a distinct perspective to his journalistic work. His journey reflects his commitment to reporting, communication and sharing meaningful stories.
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SUBSCRIBE NOW

Subscribe to our newsletter to get our newest articles instantly!

[mc4wp_form]

HOT NEWS

A microphone and sound waves

How to Record a Family Story That People Can Find and Listen to Later

Record a short family oral history on your phone, agree on who can hear it…

November 19, 2026
Two crossing orbital rings with opposite nodes

Rahu, Ketu and the Two Crossings of the Moon’s Orbit

Why Jyotish charts place Rahu and Ketu opposite each other, and how the lunar nodes…

November 19, 2026
Four subdivisions in an arc

What a Nakshatra Pada Means in a Jyotish Birth Chart

Learn how a pada divides a nakshatra and why birth-time and chart settings matter when…

November 19, 2026

YOU MAY ALSO LIKE

Rahu, Ketu and the Two Crossings of the Moon’s Orbit

Why Jyotish charts place Rahu and Ketu opposite each other, and how the lunar nodes are involved in the geometry…

AstrologyTop News
November 19, 2026

What a Nakshatra Pada Means in a Jyotish Birth Chart

Learn how a pada divides a nakshatra and why birth-time and chart settings matter when an entry is close to…

AstrologyTop News
November 19, 2026

How to Stop Window Draughts While Keeping Your Home Ventilated

Find gaps around windows and doors, choose a removable seal where suitable and leave deliberate ventilation openings clear.

LifestyleTop News
November 19, 2026

How to Test a Cycle Commute Before Relying on It for Work

Plan a quieter route, time a practice ride and check parking and return options before making your first cycle commute…

LifestyleTop News
November 19, 2026
Copyright © 2025-2026 MP Media. All rights reserved.

About Us

The Popular Story is a digital magazine and news publication bringing you stories from entertainment, sports, lifestyle, astrology and the world, with a focus on clear, original and reliable reporting.

Quick Links

  • About The Popular Story
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • Editorial Policy
  • Corrections Policy
  • Our Team

Follow us on Social Media

Explore

  • Contact Us
  • Entertainment
  • Sports
  • Lifestyle

Latest Magazine

View Magazine
© 2026 The Popular Story. All rights reserved.Privacy
Welcome Back!

Sign in to your account

Lost your password?